Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Watson Pharmaceuticals Announces Approval of Amphastar’s Generic LOVENOX(R)

September 20, 2011 By Bio-Medicine.Org

PARSIPPANY, N.J., Sept. 19, 2011 /PRNewswire/ — Watson
Pharmaceuticals, Inc. (NYSE:
WPI
) today announced that Amphastar Pharmaceuticals, Inc., has
received U.S. Food and Drug Administration (“FDA”) approval of its
Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium
Injection in the 100mg/mL and 150mg/mL strengths.  Enoxaparin
Sodium Injection is the generic equivalent to Sanofi-aventis’
LOVENOX®, and is a low molecular weight heparin indicated in
the prophylaxis and treatment of deep vein thrombosis and
prophylaxis of ischemic complications in unstable angina and
non-Q-wave myocardial infarction.  

Pursuant to the terms of the parties’ exclusive Distribution
Agreement, Amphastar will supply Enoxaparin Sodium Injection to
Watson, which will market, sell and distribute the product to the
U.S. retail pharmacy channel.  Amphastar will receive between
50 and 55 percent of Watson’s gross profits on product sales,
depending on the number of competitors in the market.
 Amphastar will market, sell and distribute the product to all
other channels.  For the 12-months ending July 30, 2011,
LOVENOX® and its generic equivalents had total U.S. sales of
approximately $2.6 billion, according to IMS Health.
 Amphastar is currently preparing for launch and anticipates
launching its Enoxaparin Sodium Injection product in the fourth
quarter of 2011.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals,
Inc. is an integrated global specialty pharmaceutical company. The
Company is engaged in the development, manufacturing, marketing and
distribution of generic pharmaceuticals and specialized branded
pharmaceutical products focused on Urology and Women’s Health.
Watson has operations in many of the world’s established and
growing international markets.

For press release and other company information, visit Watson
Pharmaceuticals

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech